quinazolines has been researched along with su 1498 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ali, N; Fujita, Y; Ishizawa, K; Izawa, Y; Kanematsu, Y; Ohnishi, H; Tamaki, T; Tsuchiya, K; Yoshizumi, M | 1 |
| Jin, SM; Kim, SR; Lee, KS; Lee, YC; Min, KH; Park, SJ; Puri, KD | 1 |
| Amin, DN; Bielenberg, DR; Heymach, JV; Klagsbrun, M; Lifshits, E | 1 |
3 other study(ies) available for quinazolines and su 1498
| Article | Year |
|---|---|
Transactivation of fetal liver kinase-1/kinase-insert domain-containing receptor by lysophosphatidylcholine induces vascular endothelial cell proliferation.
Topics: Atherosclerosis; Benzoquinones; Blotting, Western; Cell Line; Cell Proliferation; Cell Survival; Cells, Cultured; Cinnamates; CSK Tyrosine-Protein Kinase; Disease Progression; Endothelial Cells; Endothelium, Vascular; Humans; Immunoblotting; Immunoprecipitation; Lactams, Macrocyclic; Ligands; Lysophosphatidylcholines; Phosphorylation; Protein Structure, Tertiary; Protein-Tyrosine Kinases; Pyrimidines; Quinazolines; Quinones; Rifabutin; src-Family Kinases; Transcriptional Activation; Transfection; Vascular Endothelial Growth Factor Receptor-2 | 2006 |
Phosphoinositide 3-kinase-delta inhibitor reduces vascular permeability in a murine model of asthma.
Topics: Adenine; Animals; Asthma; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid; Capillary Permeability; Cinnamates; Class I Phosphatidylinositol 3-Kinases; Cytokines; Disease Models, Animal; Enzyme Inhibitors; Female; Hypoxia-Inducible Factor 1, alpha Subunit; Indoles; Leukocyte Count; Lung; Mice; Mice, Inbred BALB C; Ovalbumin; Phosphoinositide-3 Kinase Inhibitors; Pneumonia; Quinazolines; Receptors, Vascular Endothelial Growth Factor; Vascular Endothelial Growth Factor A | 2006 |
Targeting EGFR activity in blood vessels is sufficient to inhibit tumor growth and is accompanied by an increase in VEGFR-2 dependence in tumor endothelial cells.
Topics: Animals; Cell Line; Cell Line, Tumor; Cell Proliferation; Cinnamates; Endothelial Cells; Endothelium, Vascular; Enzyme Inhibitors; Epidermal Growth Factor; ErbB Receptors; Extracellular Signal-Regulated MAP Kinases; Gefitinib; Humans; Male; Mice; Mice, Nude; Neoplasms, Experimental; Neuropilin-1; Phosphorylation; Proto-Oncogene Proteins c-akt; Quinazolines; Receptor, ErbB-2; Signal Transduction; Transplantation, Heterologous; Tyrphostins; Vascular Endothelial Growth Factor Receptor-2 | 2008 |